William J. Link Ph.D., Director at Tarsus Pharmaceuticals, Inc. (TARS), sold 144,892 shares at $26.01 ($1.8M) on 2024-08-12, disclosed to the SEC on 2024-08-14.
Open-market sale of $1.8M TARS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 74,892 | $0 | 0.0% |
| 2 | $26.01 | 29,979 | $780K | 42.7% |
| 3 | $26.01 | 29,979 | $780K | 42.7% |
| 4 | $26.53 | 5,021 | $133K | 7.3% |
| 5 | $26.53 | 5,021 | $133K | 7.3% |
| Total | $12.60 avg | 144,892 |
| $1.8M |
| 100% |
| Filing → |
| TARS | SELL | 2026-03-18 | $860K | — | Filing → |
| TARS | SELL | 2025-12-17 | $3.3M | — | Filing → |
| TARS | SELL | 2025-09-10 | $1.5M | — | Filing → |